Delivery Order HHSN261201500026I-HHSN26100002
Award Date 9/25/15
Potential Completion Date 12/31/21
Potential Value $1.9M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Champaign, IL 61820, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the National Cancer Institute, a civilian agency under the U.S. Department of Health and Human Services, to the University of Illinois for a "CONTRACT ORIENTATION AND KICKOFF MEETING" from September 30, 2015 to December 31, 2015. The award, which has a ceiling value of $2,587.19, is a delivery order under the PREVENT Toxicology and Pharmacology Testing (PREVENT TOX) indefinite delivery/indefinite quantity (IDIQ) contract. The contract has a...
- This is a definitive contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to the University of Illinois for preclinical pharmacology and toxicology studies. The contract, valued at $24,207,156.38, does not have a set-aside designation. The University of Illinois, a major public research institution, is conducting research and development work to support the PREVENT Cancer Preclinical Drug Development Program, a structured...
- This federal contract award, valued at $149,395.10, was issued by the Centers for Disease Control and Prevention (CDC) to the University of Illinois, a major public research university system. The contract is for professional and consulting services and does not have a set-aside designation. The University of Illinois has been awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract from the National Cancer Institute, valued at $149,995,000, to support the PREVENT Cancer Preclinical...
- This is a federal contract award to the University of Illinois, a major public research university, by the Office of the Assistant Secretary for Preparedness and Response (ASPR). The contract, valued at $2,062,263.00, is for research and development services related to chemical and radiological/nuclear agent countermeasures. It is a delivery order under the BARDA Chem and RadNuc Animal Model 2015-2020 Indefinite Delivery Indefinite Quantity (IDIQ) contract. This IDIQ contract, valued at...
- The National Cancer Institute issued a delivery order to the University of Illinois on September 17, 2018, for preclinical toxicology and pharmacology research on a dual AKT/PDPK1 inhibitor for actinic keratosis and skin cancer prevention in immunocompromised individuals, with a ceiling value of $2,273,213.36. The order is issued under the PREVENT Toxicology and Pharmacology Testing (PREVENT TOX) parent IDIQ. Place of performance is Urbana, IL. The order is firm fixed price with an ultimate...
- This federal contract award is a definitive contract between the University of Illinois, doing business as The Board of Trustees of the University of Illinois, and the U.S. government. The contract has a potential value of $200,000.00 and was awarded on May 15, 2001, with a completion date of December 31, 2006. The contract does not have a set-aside designation. The University of Illinois is a major public research university system that has performed a wide range of research and development...
- <p>The National Cancer Institute issued a $3,500 delivery order to the University of Illinois on January 24, 2019, for contract orientation and kickoff meeting activities under the PREVENT Preclinical Drug Development Program (PREVENT).</p> <p>Place of performance is Bristol, IL. The order period ran from January 25, 2019 through February 24, 2019. Work is priced on a cost-plus-fixed-fee basis with no set-aside applied.</p>
- This federal contract award with award ID HHSN261201500024I|HHSN26100003 was issued by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS). The $321,110.80 award was made on September 15, 2016 to the IIT Research Institute (IITRI), a non-profit research organization and division of the Illinois Institute of Technology (IIT). The contract is for the "PRECLINICAL EVALUATION OF A NEW LIPID-BASED SMEDDS" under the NCI's PREVENT...
- This federal contract award from the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a division of the Illinois Institute of Technology, is for a $596,209 Firm Fixed Price Delivery Order under the "PREVENT Cancer Program (PREVENT)" contract vehicle. The contract is for the "NOVEL ANDROGEN RECEPTOR ANTAGONIST-MEDIATED CHEMOPREVENTION OF PROSTATE CANCER" project, which aims to conduct preclinical research to support the development of therapies for...
- This federal contract award to the University of Illinois, doing business as The Board of Trustees of the University of Illinois, was issued by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), a civilian agency. The $633,029.25 cost-no-fee definitive contract is for biomedical research and exploratory work, with a completion date of June 3, 2013. The University of Illinois has extensive experience as both a prime contractor and subcontractor...